Ousted CEO of Vancouver biotech indicted for alleged securities fraud


Former CytoDyn CEO Nader Pourhassan allegedly made false and misleading representations about the company's investigational drug, leronlimab.

Previous 2022 sees big changes in health care leadership
Next Research Roundup: U of M, Shelby County Health Department score $13.83M grant from CDC